Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib

BACKGROUND: The aim of the study was to investigate whether RCC patients with oligometastatic state of bone metastasis treated with sunitinib had a favorable clinical outcome. RESULTS: 22 patients were classified into oligometastatic state of bone metastasis with a median OS of 30.1 months (95%CI: 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Xiaolin, Gu, Weijie, Zhang, Hailiang, Zhu, Yao, Shi, Guohai, Ye, Dingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042022/
https://www.ncbi.nlm.nih.gov/pubmed/27058898
http://dx.doi.org/10.18632/oncotarget.8568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042022/
https://www.ncbi.nlm.nih.gov/pubmed/27058898
http://dx.doi.org/10.18632/oncotarget.8568

Ejemplares similares